BA
36
-4
D
63
2
AAPL
40
-2
MPC
50
4
AMP
63
3
ADT
40
3
CNP
54
4
URBN
30
3
CVX
38
3
APD
44
4
GOOGL
50
2
RRC
46
-2
CF
59
3
ITW
64
2
PPG
64
4
GOOG
53
2
SWKS
51
3
DIS
54
2
MMC
65
-2
MO
38
2
BA
36
-4
D
63
2
AAPL
40
-2
MPC
50
4
AMP
63
3
ADT
40
3
CNP
54
4
URBN
30
3
CVX
38
3
APD
44
4
GOOGL
50
2
RRC
46
-2
CF
59
3
ITW
64
2
PPG
64
4
GOOG
53
2
SWKS
51
3
DIS
54
2
MMC
65
-2
MO
38
2
Financhill
Back

Ladder Capital Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
50

LADR
Ladder Capital

Last Price:
12.19
Seasonality Move:
2.72%
Sell
25

ALNY
Alnylam Pharmaceuticals

Last Price:
265.13
Seasonality Move:
5.61%
Sell
50
Ladder Capital (LADR) is a Sell

Is Ladder Capital a Buy, Sell or Hold?

  • The current Ladder Capital [LADR] share price is $12.20. The Score for LADR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • LADR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $265.27. The Score for ALNY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LADR Stock Price Chart

What is Ladder Capital's stock price today?

  • The Ladder Capital share price today is $12.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LADR is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $265.27
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

LADR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 58.98 Buy
Chaikin Money Flow: 549893 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.72 - 12.14) Buy
Bollinger Bands (100): (11.01 - 11.95) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.4 Buy
Relative Strength Index (14 RSI): 53.6 Buy
Chaikin Money Flow: 403934 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (256.2 - 277.22) Sell
Bollinger Bands (100): (158.9 - 265.08) Buy

LADR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12 Buy
20-day SMA: 12 Buy
50-day SMA: 11.88 Buy
200-day SMA: 11.26 Buy
8-day EMA: 12.04 Buy
20-day EMA: 11.99 Buy
50-day EMA: 11.82 Buy
200-day EMA: 11.29 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 256.17 Buy
20-day SMA: 266.77 Sell
50-day SMA: 258.27 Buy
200-day SMA: 189.51 Buy
8-day EMA: 260.57 Buy
20-day EMA: 261.96 Buy
50-day EMA: 250.03 Buy
200-day EMA: 205.35 Buy

Ladder Capital Earnings Growth & LADR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.08 per share, and an increase next year of $0.07 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.

Ladder Capital Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):